Phase I-II trial of a monoclonal anti-tumor necrosis factor α antibody for the treatement of refractory severe acute graft-versus-host disease
- Author
- HERVE, P1 ; FLESCH, M; LIOURE, B; ROCHE, C; VILMER, E; DEMEOCQ, F; KUENTZ, M; CAHN, J. Y; TIBERGHIEN, P; WIJDENES, J; RACADOT, E; BORDIGONI, P; PLOUVIER, E; STEPHAN, J. L; BOURDEAU, S. H; HOLLER, E
[1] Cent. régional transfusion sanguine, 25000 Besançon, France - Source
Blood. 1992, Vol 79, Num 12, pp 3362-3368 ; ref : 26 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- The Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aigu Anticorps monoclonal Essai clinique Facteur nécrose tumorale α Homme Immunothérapie Maladie greffon hôte Traitement Hémopathie Immunopathologie
- Keyword (en)
- Acute Monoclonal antibody Clinical trial Tumor necrosis factor α Human Immunotherapy Graft versus host reaction Treatment Hemopathy Immunopathology
- Keyword (es)
- Agudo Anticuerpo monoclonal Ensayo clínico Factor necrosis tumoral α Hombre Inmunoterapia Enfermedad injerto huesped Tratamiento Hemopatía Inmunopatología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 5449165
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood.V79.12.3362.bloodjournal79123362 
https://dx.doi.org/10.1182/blood.V79.12.3362.bloodjournal79123362
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3362\";s:8:\"\u0000*\u0000epage\";s:4:\"3368\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HERVE\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:9:\"FLESCH, M\";i:1;s:9:\"LIOURE, B\";i:2;s:8:\"ROCHE, C\";i:3;s:9:\"VILMER, E\";i:4;s:10:\"DEMEOCQ, F\";i:5;s:9:\"KUENTZ, M\";i:6;s:10:\"CAHN, J. Y\";i:7;s:13:\"TIBERGHIEN, P\";i:8;s:11:\"WIJDENES, J\";i:9;s:10:\"RACADOT, E\";i:10;s:12:\"BORDIGONI, P\";i:11;s:11:\"PLOUVIER, E\";i:12;s:13:\"STEPHAN, J. L\";i:13;s:14:\"BOURDEAU, S. H\";i:14;s:9:\"HOLLER, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3362\";s:8:\"\u0000*\u0000epage\";s:4:\"3368\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HERVE\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:9:\"FLESCH, M\";i:1;s:9:\"LIOURE, B\";i:2;s:8:\"ROCHE, C\";i:3;s:9:\"VILMER, E\";i:4;s:10:\"DEMEOCQ, F\";i:5;s:9:\"KUENTZ, M\";i:6;s:10:\"CAHN, J. Y\";i:7;s:13:\"TIBERGHIEN, P\";i:8;s:11:\"WIJDENES, J\";i:9;s:10:\"RACADOT, E\";i:10;s:12:\"BORDIGONI, P\";i:11;s:11:\"PLOUVIER, E\";i:12;s:13:\"STEPHAN, J. L\";i:13;s:14:\"BOURDEAU, S. H\";i:14;s:9:\"HOLLER, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3362\";s:8:\"\u0000*\u0000epage\";s:4:\"3368\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HERVE\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:9:\"FLESCH, M\";i:1;s:9:\"LIOURE, B\";i:2;s:8:\"ROCHE, C\";i:3;s:9:\"VILMER, E\";i:4;s:10:\"DEMEOCQ, F\";i:5;s:9:\"KUENTZ, M\";i:6;s:10:\"CAHN, J. Y\";i:7;s:13:\"TIBERGHIEN, P\";i:8;s:11:\"WIJDENES, J\";i:9;s:10:\"RACADOT, E\";i:10;s:12:\"BORDIGONI, P\";i:11;s:11:\"PLOUVIER, E\";i:12;s:13:\"STEPHAN, J. L\";i:13;s:14:\"BOURDEAU, S. H\";i:14;s:9:\"HOLLER, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3362\";s:8:\"\u0000*\u0000epage\";s:4:\"3368\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HERVE\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:9:\"FLESCH, M\";i:1;s:9:\"LIOURE, B\";i:2;s:8:\"ROCHE, C\";i:3;s:9:\"VILMER, E\";i:4;s:10:\"DEMEOCQ, F\";i:5;s:9:\"KUENTZ, M\";i:6;s:10:\"CAHN, J. Y\";i:7;s:13:\"TIBERGHIEN, P\";i:8;s:11:\"WIJDENES, J\";i:9;s:10:\"RACADOT, E\";i:10;s:12:\"BORDIGONI, P\";i:11;s:11:\"PLOUVIER, E\";i:12;s:13:\"STEPHAN, J. L\";i:13;s:14:\"BOURDEAU, S. H\";i:14;s:9:\"HOLLER, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:46:\"10.1182\/blood.V79.12.3362.bloodjournal79123362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3362\";s:8:\"\u0000*\u0000epage\";s:4:\"3368\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HERVE\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:9:\"FLESCH, M\";i:1;s:9:\"LIOURE, B\";i:2;s:8:\"ROCHE, C\";i:3;s:9:\"VILMER, E\";i:4;s:10:\"DEMEOCQ, F\";i:5;s:9:\"KUENTZ, M\";i:6;s:10:\"CAHN, J. Y\";i:7;s:13:\"TIBERGHIEN, P\";i:8;s:11:\"WIJDENES, J\";i:9;s:10:\"RACADOT, E\";i:10;s:12:\"BORDIGONI, P\";i:11;s:11:\"PLOUVIER, E\";i:12;s:13:\"STEPHAN, J. L\";i:13;s:14:\"BOURDEAU, S. H\";i:14;s:9:\"HOLLER, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatement of refractory severe acute graft-versus-host disease\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
